Cancer clinical trials in the region Pays de la Loire

190 currently recruiting clinical trials
Region Pays de la Loire

Phase 1 / Phase 2 Lung cancer
#NCT04143711
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic HER2 Immunotherapy Chemotherapy 1 2 3 or more
Systemic Treatment-Naive
7 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Dragonfly Therapeutics
Phase 1 / Phase 2 Breast cancer
#NCT04143711
HER2 Low HER2 Positive Locally Advanced Metastatic Targeted therapy Antibody Drug Conjugates (ADC) 1 2 3 or more
Systemic Treatment-Naive
6 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Dragonfly Therapeutics
Phase 1 / Phase 2 Lung cancer
#NCT04104776
SCLC (Small Cell Lung Cancer) NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic ARID1A 1 2 3 or more
Systemic Treatment-Naive
6 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes)
Constellation Pharmaceutique
Phase 1 / Phase 2 Lung cancer
#NCT04104776
Mesothelium Locally Advanced Metastatic Other mutation 1 2 3 or more
Systemic Treatment-Naive
6 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes)
Constellation Pharmaceutique
Phase 1 / Phase 2 Breast cancer
#NCT04104776
Locally Advanced Metastatic ARID1A 1 2 3 or more
Systemic Treatment-Naive
5 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes)
Constellation Pharmaceutique
Phase 1 / Phase 2 Lymphoma
#NCT04104776
B cell lymphoma Large B cell lymphoma None Treated / Controled 2 3 or more
Systemic Treatment-Naive Allogeneic stem cell transplant
6 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes)
Constellation Pharmaceutique
Phase 1 / Phase 2 Lymphoma
#NCT04104776
T cell lymphoma Peripheral T cell lymphoma None Treated / Controled 1 2 3 or more
Systemic Treatment-Naive Allogeneic stem cell transplant
6 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes)
Constellation Pharmaceutique
Phase 1 / Phase 2 Prostate cancer
#NCT04104776
Metastatic Castration-resistant ARID1A 1 2 3 or more
Systemic Treatment-Naive
5 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes)
Constellation Pharmaceutique
Phase 1 / Phase 2 Liver and bile duct cancer
#NCT05908786
Hepatocellular carcinoma Localized Systemic Treatment-Naive None Healthy
Surgery Percutaneous ethanol injection Radiofrequency ablation Transplant
7 main criterias to confirm
Centre Eugene Marquis (Rennes)
Hoffmann-La Roche
Phase 1 / Phase 2
#NCT05544552
Locally Advanced Metastatic FGFR
Systemic Treatment-Naive
3 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Tyra Biosciences, Inc